Penn Medicine - Perelman Center for Advanced Medicine is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.
Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.
Penn Medicine - Perelman Center for Advanced Medicine has participated in 5 clinical trials with 4 currently active.
Therapeutic areas: B-Cell Non-Hodgkin Lymphoma, Relapsed B-Cell Non-Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma.
Sponsors: ADC Therapeutics S.A., American Society of Clinical Oncology, Denovo Biopharma LLC.
Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Penn Medicine - Perelman Center for Advanced Medicine has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Penn Medicine - Perelman Center for Advanced Medicine has 5 clinical trials on record, with 4 currently active. Their work covers B-Cell Non-Hodgkin Lymphoma, Relapsed B-Cell Non-Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma.
Yes — Penn Medicine - Perelman Center for Advanced Medicine holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.